Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.
Article in Clinical Cancer Research (January 2024)
The most recent citing publications are shown below. View all 91 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (January 2024)
Article in Journal of Health Science and Medical Research (October 2023)
Article in Clinical Cancer Research (June 2023)